Cargando…
Ovarian Damage During Chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility
Women with autoimmune diseases such as lupus, scleroderma, and vasculitis receiving cyclophosphamide for severe disease manifestations risk primary ovarian insufficiency (POI) due to gonadotoxicity of this therapy. In addition to loss of reproductive potential, POI is associated with increased risk...
Autores principales: | Marder, Wendy, Fisseha, Senait, Ganser, Martha A., Somers, Emily C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747568/ https://www.ncbi.nlm.nih.gov/pubmed/23970822 http://dx.doi.org/10.4137/CMRH.S10415 |
Ejemplares similares
-
Rheumatic autoimmune diseases in women and midlife health
por: Marder, Wendy, et al.
Publicado: (2015) -
Beyond the Unknown: A Broad Framing for Preparedness for Emerging Infectious Threats
por: Christofferson, Rebecca C., et al.
Publicado: (2022) -
Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond
por: Ekins, Sean, et al.
Publicado: (2020) -
Perspectives on Ovarian Cancer 1809 to 2022 and Beyond
por: Lawton, Frank G., et al.
Publicado: (2022) -
Genomic Consideration in Chemotherapy-Induced Ovarian Damage and Fertility Preservation
por: Kim, Seongmin, et al.
Publicado: (2021)